Hind.Bio Science — 360° view

Hind.Bio Science, a company in the Software Products industry, reported revenue of ₹0.82 crore and net profit of ₹0.31 crore for the September 2026 quarter.

Hind.Bio Science (BSE: HINDBIO) closed at ₹6.39 on 20 Nov 2026, down 2.7% over the past year. Its market capitalisation is ₹7 crore and it trades at 41.0 times earnings.

Share price
₹6.39 (20 Nov 2026)
Market cap
₹7 Cr (20 Nov 2026)
P/E
40.97 (20 Nov 2026)
Revenue
₹1 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
-0.91% (FY26)
ROE
-3.47% (FY26)
Book value
₹1.00 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹9.92 / ₹5.00 (20 Nov 2026)
1-year return
-2.7% (to 20 Nov 2026)
Sector
Information Technology
Industry
Software Products
Symbol
BSE: HINDBIO

Incorporated in 2000, Hindustan Biosciences Ltd manufactures & sells pharmaceutical products.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.